Drug intelligence / Profile preview

Huoxiang Anwei

Development stage: Unknown
Lead developer: Shenzhen Traditional Chinese Medicine Hospital
Administration: Oral

Overview

Huoxiang Anwei is a Traditional Chinese Medicine (TCM) herbal preparation, specifically formulated as a capsule, developed by the Spleen and Stomach Department of the Shenzhen Hospital of Traditional Chinese Medicine. It is primarily indicated for the treatment of Helicobacter pylori infection. The name "Huoxiang Anwei" suggests the inclusion of Agastache rugosa (Huoxiang) and a therapeutic focus on "soothing the stomach" (Anwei). The drug is intended to provide an evidence-based clinical program for H. pylori eradication, potentially offering an alternative or adjunct to standard antibiotic triple or quadruple therapies. It is currently undergoing evaluation in randomized controlled clinical trials to assess its efficacy and safety in forming clinical guidelines.

Brand names: Huoxiang Anwei Capsule
Other names: Huoxiang Anwei capsule藿香安胃胶囊

Beyond the preview

Go deeper on Huoxiang Anwei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huoxiang Anwei.

Explore the full profile